Smoking motivations and quitting motivations among HIV-infected smokers

Antiviral Therapy

Volumn 14, Issue 6, 2009, Pages 781-787

  Peretti Watel, Patrick ^a,b   Garelik, Daniel ^c   Baron, Gabriel ^d,e   Spire, Bruno ^a,b   Ravaud, Philippe ^d,e   Duval, Xavier ^f  

^a AIX MARSEILLE UNIV   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d BICHAT HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PRIORITY JOURNAL; SIDE EFFECT; SMOKING CESSATION; SMOKING HABIT; SOCIAL SUPPORT; TOBACCO DEPENDENCE; WEIGHT CONTROL;

ADULT; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOTIVATION; QUESTIONNAIRES; SMOKING; SMOKING CESSATION;

EID: 72049088241     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1292     Document Type: Article

References (24)

1. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 2000; 31:808-812. (Pubitemid 32295508)
2. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS 2002; 16:39-42. (Pubitemid 34118921)
3. Duval X, Baron G, Garelik D, et al. Living with HIV, antiretroviral treatment (ART) experience and tobacco smoking: results from a multi-site cross-sectional study. Antivir Ther 2008; 13:389-397. (Pubitemid 352016732)
4. Peretti-Watel P, Spire B, Lert F, Obadia Y. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRSEN12- VESPA 2003). Drug Alcohol Depend 2006; 82 Suppl 1:S71-S79. (Pubitemid 43850179)
5. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6:99-106.
6. Lavole A, Wislez M, Antoine M, Mayaud C, Milleron B, Cadranel J. Lung cancer, a new challenge in the HIV-infected population. Lung Cancer 2006; 51:1-11. (Pubitemid 43088620)
7. Diaz PT, Wewers MD, Pacht E, Drake J, Nagaraja HN, Clanton TL. Respiratory symptoms among HIV-seropositive individuals. Chest 2003; 123:1977-1982.
8. Haigentz M. Aerodigestive cancers in HIV infection. Curr Opin Oncol 2005; 17:474-478.
9. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 2006; 18:469-478. (Pubitemid 44199843)
10. Miguez-Burbano MJ, Shor-Posner G, Hadrigan S. Non-tuberculous mycobacteria in HIV-infected patients: geographic, behavioural, and immunological factors. Lancet Infect Dis 2005; 5:394-395.
11. Kohli R, Lo Y, Homel P. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV Epidemiologic Research (HER) Study. Clin Infect Dis 2006; 43:90-98.
12. Patel N, Talwar A, Reichert VC, Brady T, Jain M, Kaplan MH. Tobacco and HIV. Clin Occup Environ Med 2006; 5:193-207.
13. Seaberg EC, Munoz A, Lu M, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19:953-960.
14. Levy AR, McCandless L, Harrigan PR, et al. Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS. Lipids Health Dis 2005; 4:4. (Pubitemid 40397725)
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-370.
16. Beresford TP, Blow FC, Hill E, Singer K, Lucey MR. Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet 1990; 336:482-485. (Pubitemid 20264223)
17. Boyd TC, Boyd CJ, Greenlee TB. A means to an end: slim hopes and cigarette advertising. Health Promot Pract 2003; 4:266-277.
18. Ikard F, Green DE, Horn D. A scale to differentiate between types of smoking as related to the management of affect. Int J Addict 1969; 4:649-659.
19. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119-1127.
20. Aubin H, Lagrue G, Legeron P, et al. [Building and validation of a questionnaire for measuring motivation to quit smoking]. Alccologie addictologie 2004; 26:311-316. French.
21. Everitt B. Cluster analysis. London: Edward Arnold 1993.
22. Slama K, Karsenty S, Hirsch A. Effectiveness of minimal intervention by general practitioners with their smoking patients: a randomised, controlled trial in France. Tob Control 1995; 4:162-169.
23. Butler CC, Pill R, Stott NC. Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion. BMJ 1998; 316:1878-1881. (Pubitemid 28276936)
24. Tomeo CA, Field AE, Berkey CS, Colditz GA, Frazier AL. Weight concerns, weight control behaviors, and smoking initiation. Pediatrics 1999; 104:918-924. (Pubitemid 29463561)